National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders.

ABSTRACT:

Objectives

A national survey evaluated the availability of naltrexone as a treatment for alcohol use disorder and/or opioid use disorder for pregnant individuals. Provider perceptions of barriers to treatment with naltrexone during pregnancy were also examined.

Methods

Sites were selected from a national registry of naltrexone prescribers (N = 5208). A 10% sampling of sites within 150 miles of each state's capital was selected (n = 2073). Survey of 11 questions included availability of naltrexone for pregnant individuals, standard practices for treating pregnant individuals already on naltrexone, and barriers to treatment. Survey responses were summarized to identify top barriers and national trends in service availability.

Results

Of the 236 sites contacted, 78 (33.1

SUBMITTER: Deflorimonte C 

PROVIDER: S-EPMC10873530 | biostudies-literature | 2023 Nov-Dec 01

REPOSITORIES: biostudies-literature